search
Back to results

Treatment of Early Childhood Depression (PaCT_RCTwait)

Primary Purpose

Depression

Status
Recruiting
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
PaCT
Sponsored by
University of Leipzig
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression focused on measuring Early Childhood Depression

Eligibility Criteria

3 Years - 8 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 3 to 8 years
  • DSM-5 depressive disorder (Major Depression, Dysthymia, Depression NOS), adapted for young children according to the AACAP criteria
  • Written informed consent of patient's parents or guardian
  • informed verbal assent from children (age >= 6 years)

Exclusion Criteria:

  • IQ < 70
  • autism spectrum or schizophrenia spectrum disorder in the child
  • insufficient German language skills to participate in treatment (child or caregiver)
  • ongoing litigation regarding child custody
  • concurrent intensive psychotherapy
  • participation in other interventional trials
  • suspected lack of compliance

Sites / Locations

  • University of Leipzig - Department of Child and Adolescent PsychiatryRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

PaCT

Waitlist

Arm Description

Manualized Psychoanalytic short-term therapy (PaCT) for children with internalizing disorders, 20-25 sessions (1, 2). PaCT helps the child to resolve rigid conflictual internal representations/ working models by using interpretative and mentalizing techniques and drawing on therapeutic transference relationship with the child and the parent.

PaCT after a waiting period (3 months)

Outcomes

Primary Outcome Measures

Sum of depressive symptoms as indexed by the Preschool Age Psychiatric Assessment (PAPA) interview with the primary caregiver
Sum of depressive symptoms using Preschool Age Psychiatric Assessment (PAPA) at post-treatment in the treatment group compared to post-waiting period in the waitlist group (controlling for the respective pre-values) based on clinical interviews. The scale ranges from 0-9 symptoms and higher values indicate worse outcome.

Secondary Outcome Measures

Sum of PAPA depressive symptoms
Sum of depressive symptoms using the PAPA. The scale ranges from 0-9 symptoms and higher values indicate worse outcome.
Diagnosis of depression
occurrence of diagnosis of depression using PAPA
Diagnosis of anxiety disorder
occurrence of diagnosis of anxiety disorder using PAPA
Teacher-reported internalizing symptoms (TRF)
(Nursery-)teacher-rated internalizing symptoms using Teacher Report Form (TRF). The scale ranges from 0-70 with higher scores indicating worse outcomes.
Interview-based internalizing symptoms
Child self-reported internalizing symptoms using Berkeley Puppet Interview, the scale ranges from 1-182 with higher scores indicating better outcomes.
Caregiver-reported externalizing symptoms
Externalizing symptoms rated by caregiversusing Child Behavior Checklist. (CBCL 4-18) The scale ranges from 0-66 with higher scores indicating worse outcomes.
Teacher-reproted externalizing symptoms
Externalizing symptoms rated by teachers using Teacher Report Form (TRF). The scale ranges from 0-68 with higher scores indicating worse outcomes.
Cortisol secretion
hair-cortisol concentrations (HCC) in the first 3 cm scalp hair segment at posterior vertex (~cumulative secretion over last 3 months)
Internalizing symptoms reported by the primary caregiver (CBCL)
internalizing symptoms rated by primary caregivers using Child Behavior Checklist (CBCL 4-18). The scale ranges from 0-62 with higher scores indicating worse outcomes.
Internalizing symptoms reported by the secondary caregiver (CBCL)
internalizing symptoms rated by primary caregivers using Child Behavior Checklist (CBCL 4-18). The scale ranges from 0-62 with higher scores indicating worse outcomes.
Quality of the parent-child interaction (EAS)
In an exploratory fashion, the investigators will test whether the quality of parent-child interaction improve after the intervention and whether this improvement in interaction quality is a mediator of the treatment effect. Quality of the parent-child interaction assessed by the Emotional Availability Scales (EAS), specifically four caregiver scales (1. sensitivity, 2. structuring, 3. nonintrusiveness, and 4. nonhostility) and two child scales (1.responsiveness to mother and 2. involvement of mother). Codes on the scales range from 1 to 7, with higher scores indicating better outcome.
Quality of the parent-child interaction (MSSB)
In an exploratory fashion, the investigators will test whether the child's ability to mentalize improve after the intervention and whether improvment in this ability is a mediator of the treatment effect. Child's ability to mentalize assessed by the Process Scales (Hill et al., 2009) MacArthur Narrative Coding Manual (MNCM; Robsinson et al., 2002) using the indices for narrative coherence (range: 1-12), intentionality (range: 1-12), with higher scores indicating better outcome.

Full Information

First Posted
February 24, 2020
Last Updated
April 13, 2023
Sponsor
University of Leipzig
Collaborators
Technische Universität Dresden
search

1. Study Identification

Unique Protocol Identification Number
NCT04708275
Brief Title
Treatment of Early Childhood Depression
Acronym
PaCT_RCTwait
Official Title
A Waitlist Controlled Trial for Early Childhood Depression
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 24, 2020 (Actual)
Primary Completion Date
March 10, 2024 (Anticipated)
Study Completion Date
June 10, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Leipzig
Collaborators
Technische Universität Dresden

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Depression often occurs in early childhood. Moreover, later depression is frequently preceded by early childhood Depression (ECD). However, at present, there is a lack of evidence-based tratestments (EBTs) for ECD, posing a core research desideratum highlighted by both the American and German practice parameters for ECD. The current study seeks to redress this research gap, by evaluating the feasibility and dose-dependent effectiveness of manualized short-term psychoanalytic child psychotherapy (PaCT) compared to waitlist in a randomized controlled trial (RCT) among clinically referred 3 to 8-year-olds with ECD. Comprising 20-25 sessions in alternating settings (child-only, caregiver(s)-child, caregiver(s)-only), PaCT focuses on internal conflicts and representations underlying depressive disorders. PaCT targets the child-therapist relationship, using interpretative, play and mentalization-based techniques, aiming to elicit the interpersonal meaning of the child's symptoms within the child-caregiver relationship(s).
Detailed Description
For this trial, 62 clinically referred children meeting criteria for DSM-5 depressive disorders, will be randomized randomized to PaCT (n=31) or waitlist (n=31). The overarching aim is to engender reduction in depressive symptoms and diagnoses following PaCT vs. waitlist in order to determine effect sizes which can be used in power calculations for future large-scale clinical trials. Moreover, effects of PaCT will also be examined at mid-treatment to provide a first insight into the necesary therapeutic dose. Moreover, the trial will also be used as a first opportunity to examine feasibility of PaCT in young children, treatment integrity, as well as treatment acceptability.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression
Keywords
Early Childhood Depression

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
2 arms, waitlist-controlled, randomized, single masked (outcomes assessor), single-center trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
62 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
PaCT
Arm Type
Experimental
Arm Description
Manualized Psychoanalytic short-term therapy (PaCT) for children with internalizing disorders, 20-25 sessions (1, 2). PaCT helps the child to resolve rigid conflictual internal representations/ working models by using interpretative and mentalizing techniques and drawing on therapeutic transference relationship with the child and the parent.
Arm Title
Waitlist
Arm Type
Active Comparator
Arm Description
PaCT after a waiting period (3 months)
Intervention Type
Procedure
Intervention Name(s)
PaCT
Intervention Description
Manualized Psychoanalytic short-term therapy (PaCT) for children with internalizing disorders, 20-25 sessions (1, 2). PaCT helps the child to resolve rigid conflictual internal representations/ working models by using interpretative and mentalizing techniques and drawing on therapeutic transference relationship with the child and the parent.
Primary Outcome Measure Information:
Title
Sum of depressive symptoms as indexed by the Preschool Age Psychiatric Assessment (PAPA) interview with the primary caregiver
Description
Sum of depressive symptoms using Preschool Age Psychiatric Assessment (PAPA) at post-treatment in the treatment group compared to post-waiting period in the waitlist group (controlling for the respective pre-values) based on clinical interviews. The scale ranges from 0-9 symptoms and higher values indicate worse outcome.
Time Frame
post-treatment (after 20-25 weeks with weekly treatment sessions; on average after 7 months)
Secondary Outcome Measure Information:
Title
Sum of PAPA depressive symptoms
Description
Sum of depressive symptoms using the PAPA. The scale ranges from 0-9 symptoms and higher values indicate worse outcome.
Time Frame
mid-treatment (after 12 weeks with weekly treatment sessions) and follow up (3 months after intervention)
Title
Diagnosis of depression
Description
occurrence of diagnosis of depression using PAPA
Time Frame
mid-treatment (after 12 weeks with weekly treatment sessions) and follow up (3 months after intervention)
Title
Diagnosis of anxiety disorder
Description
occurrence of diagnosis of anxiety disorder using PAPA
Time Frame
pre-waitlist (before waiting period) / pre-treatment (within 3 weeks before start of intervention), post-treatment (after 20-25 weeks with weekly treatment sessions) and follow up (3 months after intervention)
Title
Teacher-reported internalizing symptoms (TRF)
Description
(Nursery-)teacher-rated internalizing symptoms using Teacher Report Form (TRF). The scale ranges from 0-70 with higher scores indicating worse outcomes.
Time Frame
pre-waitlist (before waiting period)/pre-treatment (within 3 weeks before start intervention)/mid-treatment (after 12 weeks with weekly treatment sessions)/post-treatment (after 20-25 weeks with weekly treatment sessions)/FUP (3 months post intervention)
Title
Interview-based internalizing symptoms
Description
Child self-reported internalizing symptoms using Berkeley Puppet Interview, the scale ranges from 1-182 with higher scores indicating better outcomes.
Time Frame
pre-waitlist (before waiting period), pre-treatment (within 3 weeks before start intervention), post-treatment (after 20-25 weeks with weekly treatment sessions), follow-up (3 months after intervention)
Title
Caregiver-reported externalizing symptoms
Description
Externalizing symptoms rated by caregiversusing Child Behavior Checklist. (CBCL 4-18) The scale ranges from 0-66 with higher scores indicating worse outcomes.
Time Frame
pre-waitlist (before waiting period)/pre-treatment (within 3 weeks before start intervention)/mid-treatment (after 12 weeks with weekly treatment sessions)/post-treatment (after 20-25 weeks with weekly treatment sessions)/FUP (3 months post intervention)
Title
Teacher-reproted externalizing symptoms
Description
Externalizing symptoms rated by teachers using Teacher Report Form (TRF). The scale ranges from 0-68 with higher scores indicating worse outcomes.
Time Frame
pre-waitlist (before waiting period)/pre-treatment (within 3 weeks before start intervention)/mid-treatment (after 12 weeks with weekly treatment sessions)/post-treatment (after 20-25 weeks with weekly treatment sessions)/FUP (3 months post intervention)
Title
Cortisol secretion
Description
hair-cortisol concentrations (HCC) in the first 3 cm scalp hair segment at posterior vertex (~cumulative secretion over last 3 months)
Time Frame
pre-waitlist (before waiting period)/pre-treatment (within 3 weeks before start intervention)/mid-treatment (after 12 weeks with weekly treatment sessions)/post-treatment (after 20-25 weeks with weekly treatment sessions)/FUP (3 months post intervention)
Title
Internalizing symptoms reported by the primary caregiver (CBCL)
Description
internalizing symptoms rated by primary caregivers using Child Behavior Checklist (CBCL 4-18). The scale ranges from 0-62 with higher scores indicating worse outcomes.
Time Frame
pre-waitlist (before waiting period)/pre-treatment (within 3 weeks before start intervention)/mid-treatment (after 12 weeks with weekly treatment sessions)/post-treatment (after 20-25 weeks with weekly treatment sessions)/FUP (3 months post intervention)
Title
Internalizing symptoms reported by the secondary caregiver (CBCL)
Description
internalizing symptoms rated by primary caregivers using Child Behavior Checklist (CBCL 4-18). The scale ranges from 0-62 with higher scores indicating worse outcomes.
Time Frame
pre-waitlist (before waiting period)/pre-treatment (within 3 weeks before start intervention)/mid-treatment (after 12 weeks with weekly treatment sessions)/post-treatment (after 20-25 weeks with weekly treatment sessions)/FUP (3 months post intervention)
Title
Quality of the parent-child interaction (EAS)
Description
In an exploratory fashion, the investigators will test whether the quality of parent-child interaction improve after the intervention and whether this improvement in interaction quality is a mediator of the treatment effect. Quality of the parent-child interaction assessed by the Emotional Availability Scales (EAS), specifically four caregiver scales (1. sensitivity, 2. structuring, 3. nonintrusiveness, and 4. nonhostility) and two child scales (1.responsiveness to mother and 2. involvement of mother). Codes on the scales range from 1 to 7, with higher scores indicating better outcome.
Time Frame
pre-waitlist (before waiting period) / pre-treatment (within 3 weeks before start of intervention), post-treatment (after 20-25 weeks with weekly treatment sessions) and follow up (3 months after intervention)
Title
Quality of the parent-child interaction (MSSB)
Description
In an exploratory fashion, the investigators will test whether the child's ability to mentalize improve after the intervention and whether improvment in this ability is a mediator of the treatment effect. Child's ability to mentalize assessed by the Process Scales (Hill et al., 2009) MacArthur Narrative Coding Manual (MNCM; Robsinson et al., 2002) using the indices for narrative coherence (range: 1-12), intentionality (range: 1-12), with higher scores indicating better outcome.
Time Frame
pre-waitlist (before waiting period) / pre-treatment (within 3 weeks before start of intervention), post-treatment (after 20-25 weeks with weekly treatment sessions) and follow up (3 months after intervention)
Other Pre-specified Outcome Measures:
Title
Feasibility-related endpoints - Acceptability of PaCT
Description
Acceptability of PaCT rated by caregivers/ parents using Treatment evaluation questionnaire (FBB)
Time Frame
post-treatment (after 20-25 weeks with weekly treatment sessions)
Title
Feasibility-related endpoints - Acceptability of PaCT rated by children
Description
Acceptability of PACT rated by children: Items derived from the German version of Therapeutic Alliance Scales for Children (TASC) assessed by Berkeley Puppet Interview technique (BPI)
Time Frame
post-treatment (after 20-25 weeks with weekly treatment sessions)
Title
Feasibility-related endpoints - Acceptability of PaCT rated by therapists
Description
Acceptability of PaCT rated by therapists using Treatment evaluation questionnaire (FBB)
Time Frame
post-treatment (after 20-25 weeks with weekly treatment sessions)
Title
Feasibility-related endpoints - retention rates
Description
Acceptability of PaCT: retention rates - the investigators expect a high rate of retention until post-treatment (expected 85%-90%)
Time Frame
post-treatment (after 20-25 weeks with weekly treatment sessions)
Title
Feasibility-related endpoints - adherence to PaCT
Description
Adherence to PACT interventions: coding of session videos using a Q-sort rating
Time Frame
during all therapeutic sessions (20-25 weeks with weekly treatment sessions)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 3 to 8 years DSM-5 depressive disorder (Major Depression, Dysthymia, Depression NOS), adapted for young children according to the AACAP criteria Written informed consent of patient's parents or guardian informed verbal assent from children (age >= 6 years) Exclusion Criteria: IQ < 70 autism spectrum or schizophrenia spectrum disorder in the child insufficient German language skills to participate in treatment (child or caregiver) ongoing litigation regarding child custody concurrent intensive psychotherapy participation in other interventional trials suspected lack of compliance
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lars Otto White, Dr. phil.
Phone
+49 (0) 341 - 9724018
Email
LarsOtto.White@medizin.uni-leipzig.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kai von Klitzing, Prof.Dr.
Organizational Affiliation
University of Leipzig - Department of Child and Adolescent Psychiatry
Official's Role
Study Chair
Facility Information:
Facility Name
University of Leipzig - Department of Child and Adolescent Psychiatry
City
Leipzig
ZIP/Postal Code
04103
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kai von Klitzing, Prof.Dr.

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
After publication of the primary objective, published data might be provided to interested scientists on request (e.g. for meta-analyses, health related registers or other scientific questions) in an anonymized way within 5 years, if the members of the TREAT-SAD-KIDS-trial group agree.
IPD Sharing Time Frame
after publication within 5 years
IPD Sharing Access Criteria
direct inquiry to coordinating investigators

Learn more about this trial

Treatment of Early Childhood Depression

We'll reach out to this number within 24 hrs